| Post |
| Pre |
| LA |
|---|
| 1 |
| 1 |
| ME 1 | ME 2 | ME 3 | ME 4 | ME 5 | ME 6 | ME 7 | ME 8 | ME 9 | ME 10 | Total |
|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 84 | 153 | 32 | - | - | 269 |
| - | - | - | - | - | 1 | 1 | - | - | - | 2 |
| Post |
| Pre |
| LO 1 | LO 2 | LO 3 | LO 4 | LO 5A | LO 5B | LO 6 | Total |
|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - |
| - | - | - | - | - | - | - | - |
| AME |
|---|
| 7 |
| 2 |
| Post |
| Pre |
| LOP 1 | LOP 2 | LOP 3 | LOP 4 | Total |
|---|---|---|---|---|
| - | - | - | - | - |
| - | - | - | - | - |
| central brain |
|---|
| - |
| - |

| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| ME(R) | 269 | 96.8% | -7.07 | 2 | 14.3% |
| Optic-unspecified(R) | 1 | 0.4% | 3.17 | 9 | 64.3% |
| AME(R) | 7 | 2.5% | -1.81 | 2 | 14.3% |
| LA(R) | 1 | 0.4% | 0.00 | 1 | 7.1% |
| upstream partner | # | NT | conns Lat4 | % In | CV |
|---|---|---|---|---|---|
| MeVC3 (L) | 1 | ACh | 76 | 27.7% | 0.0 |
| Cm6 (R) | 28 | GABA | 54 | 19.7% | 0.6 |
| TmY9a (R) | 7 | ACh | 27 | 9.9% | 0.4 |
| MeVC25 (R) | 1 | Glu | 14 | 5.1% | 0.0 |
| TmY17 (R) | 9 | ACh | 14 | 5.1% | 0.6 |
| MeVP7 (R) | 2 | ACh | 11 | 4.0% | 0.1 |
| MeVC5 (L) | 1 | ACh | 10 | 3.6% | 0.0 |
| Cm20 (R) | 6 | GABA | 10 | 3.6% | 0.6 |
| Cm4 (R) | 5 | Glu | 8 | 2.9% | 0.5 |
| Cm5 (R) | 5 | GABA | 6 | 2.2% | 0.3 |
| Y3 (R) | 3 | ACh | 4 | 1.5% | 0.4 |
| Tm5c (R) | 2 | Glu | 3 | 1.1% | 0.3 |
| MeVC20 (R) | 2 | Glu | 3 | 1.1% | 0.3 |
| MeLo6 (R) | 3 | ACh | 3 | 1.1% | 0.0 |
| Tm16 (R) | 3 | ACh | 3 | 1.1% | 0.0 |
| Lat2 (R) | 1 | unc | 2 | 0.7% | 0.0 |
| MeTu3c (R) | 2 | ACh | 2 | 0.7% | 0.0 |
| TmY5a (R) | 2 | Glu | 2 | 0.7% | 0.0 |
| Pm12 (R) | 2 | GABA | 2 | 0.7% | 0.0 |
| aMe17a (R) | 1 | unc | 1 | 0.4% | 0.0 |
| Cm1 (R) | 1 | ACh | 1 | 0.4% | 0.0 |
| TmY18 (R) | 1 | ACh | 1 | 0.4% | 0.0 |
| Mi17 (R) | 1 | GABA | 1 | 0.4% | 0.0 |
| Cm3 (R) | 1 | GABA | 1 | 0.4% | 0.0 |
| Mi4 (R) | 1 | GABA | 1 | 0.4% | 0.0 |
| MeTu1 (R) | 1 | ACh | 1 | 0.4% | 0.0 |
| aMe1 (R) | 1 | GABA | 1 | 0.4% | 0.0 |
| aMe2 (R) | 1 | Glu | 1 | 0.4% | 0.0 |
| Cm14 (R) | 1 | GABA | 1 | 0.4% | 0.0 |
| MeLo3b (R) | 1 | ACh | 1 | 0.4% | 0.0 |
| aMe10 (R) | 1 | ACh | 1 | 0.4% | 0.0 |
| Cm26 (R) | 1 | Glu | 1 | 0.4% | 0.0 |
| aMe26 (R) | 1 | ACh | 1 | 0.4% | 0.0 |
| MeVPMe5 (L) | 1 | Glu | 1 | 0.4% | 0.0 |
| MeVC24 (R) | 1 | Glu | 1 | 0.4% | 0.0 |
| Cm32 (R) | 1 | GABA | 1 | 0.4% | 0.0 |
| Cm31b (R) | 1 | GABA | 1 | 0.4% | 0.0 |
| MeVPMe12 (R) | 1 | ACh | 1 | 0.4% | 0.0 |
| 5-HTPMPV03 (L) | 1 | 5-HT | 1 | 0.4% | 0.0 |
| downstream partner | # | NT | conns Lat4 | % Out | CV |
|---|---|---|---|---|---|
| Lat2 (R) | 1 | unc | 4 | 40.0% | 0.0 |
| Lat5 (R) | 1 | unc | 2 | 20.0% | 0.0 |
| MeLo6 (R) | 1 | ACh | 1 | 10.0% | 0.0 |
| Lat1 (R) | 1 | unc | 1 | 10.0% | 0.0 |
| AN27X013 (R) | 1 | unc | 1 | 10.0% | 0.0 |
| 5thsLNv_LNd6 (R) | 1 | ACh | 1 | 10.0% | 0.0 |